AUG 18, 2026 · PHASE 2 TRIAL
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
ClinicalTrials.gov
This is a Phase 2, single-arm feasibility study with no results yet posted; it is designed to evaluate concurrent SBRT and immunotherapy but carries no outcome data to assess efficacy or safety.
Reported
Planned enrollment35
Primary outcome measure6-Month Progression-Free Survival (PFS)
PhasePHASE 2